Anatomy and physiology of the nose--pathophysiologic alterations in allergic rhinitis.
D000316:Adrenergic alpha-Agonists / Q000627:therapeutic use; D000318:Adrenergic beta-Agonists / Q000627:therapeutic use; D000403:Airway Resistance; D002121:Calcium Channel Blockers / Q000627:therapeutic use; D002631:Chemotactic Factors, Eosinophil / Q000502:physiology; D018680:Cholinergic Antagonists; D004205:Cromolyn Sodium / Q000627:therapeutic use; D005938:Glucocorticoids / Q000627:therapeutic use; D006632:Histamine / Q000502:physiology; D006634:Histamine H1 Antagonists; D006635:Histamine H2 Antagonists; D006801:Humans; D006893:Hydroxyeicosatetraenoic Acids / Q000502:physiology; D007975:Leukotriene B4 / Q000502:physiology; D009297:Nasal Mucosa / Q000294:innervation / Q000502:physiology; D009299:Nasal Provocation Tests; D009666:Nose / Q000033:anatomy & histology* / Q000503:physiopathology; D011453:Prostaglandins / Q000502:physiology; D012221:Rhinitis, Allergic, Perennial / Q000188:drug therapy / Q000503:physiopathology*; D013931:Thromboxanes / Q000502:physiology
D000316:Adrenergic alpha-Agonists; D000318:Adrenergic beta-Agonists; D002121:Calcium Channel Blockers; D002631:Chemotactic Factors, Eosinophil; D018680:Cholinergic Antagonists; D005938:Glucocorticoids; D006634:Histamine H1 Antagonists; D006635:Histamine H2 Antagonists; D006893:Hydroxyeicosatetraenoic Acids; D011453:Prostaglandins; D013931:Thromboxanes; D007975:Leukotriene B4; D006632:Histamine; D004205:Cromolyn Sodium